To discover ATF3-dependent therapeutic options for quiescent cancer cells, we further initiated a chemical screen using the mechanistic set provided by the National Institutes of Health (NCI), hoping to find a compound targeting cells expressing ATF3 (Fig. 4E). The gene discussed is ATF3; the disease is cancer.